Stay updated on Elafibranor in NASH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.

Latest updates to the Elafibranor in NASH: Efficacy & Safety Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedExpanded the Locations section to include numerous country/region sites worldwide and updated to revision v3.3.3; existing country/location blocks were removed.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page no longer displays the government funding status notice, and the rest of the study details and location information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedUpdated study locations list with changes to participating sites, including additions and removals. This affects where potential participants can enroll.SummaryDifference0.1%

- Check67 days agoChange DetectedTwo study sites in Santiago de Cali (760032, 760042) were removed and two new sites in Cali (760032, 760042) were added.SummaryDifference0.1%

- Check88 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference1%

Stay in the know with updates to Elafibranor in NASH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elafibranor in NASH: Efficacy & Safety Clinical Trial page.